Effective June 1, 2014, Dr. Michael Pack will become Head of Evonik Industries’ Performance Polymers Business Unit. He succeeds Gregor Hetzke, who has led the business unit since 2008, Hetzke will assume leadership of Evonik’s Advanced Intermediates Business Unit on the same day.
Pack, whose doctorate is in agricultural science, began his professional career with Degussa AG in 1990. After holding a position with Finnfeeds Int. Ltd., a British company, he returned to Degussa in 1998. Six years later he became Head of Controlling & Business Development in what was then the Feed Additives Business Unit. In 2008, he became Head of the Methionine Business Line in Evonik’s Health & Nutrition Business Unit. Pack has been responsible for the operations of Evonik’s Baby Care Business Line since 2013.
"The Performance Polymers Business Unit combines competence in high performance and specialty plastics within Evonik Industries. We support our clients as a reliable and innovative partner and offer them tailor-made solutions," said Michael Pack. "I look forward to my new task and to the further development of this business unit."
About the Performance Polymers Business Unit
The Performance Polymers Business Unit produces a wide range of high performance materials mainly for the automotive, aviation, electronics and photovoltaic industries. At its heart are integrated technology platforms for methylmethacrylat (MMA) chemistry as well as polyamide 12.
Additionally, the business unit produces materials based on polyetherether ketone (PEEK) and polyimides to meet high-tech mechanical, thermal and chemical requirements. This business unit’s activities comprise the Acrylic Monomers, Acrylic Polymers and High Performance Polymers Business Lines. Sales were around 1.8 billion Euro in 2013.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.